J Korean Med Sci.  2009 Dec;24(6):1187-1191. 10.3346/jkms.2009.24.6.1187.

The One Year Outcome after KTP Laser Vaporization of the Prostate According to the Calculated Vaporized Volume

• Ku JH
• Cho JY
• Cho SY
• Kim SW
• Paick JS

• KMID: 1783153
• DOI: http://doi.org/10.3346/jkms.2009.24.6.1187

Abstract

The aim of this study was to develop a new simple method for measuring the vaporized volume and to evaluate the outcome of high-power potassium-titanyl-phosphate (KTP) photoselective laser vaporization. A total of 65 patients, with a mean age of 67.7 yr (range 53 to 85), were included in the primary analysis. The vaporized volume was calculated as the pre-operative volume minus the immediate post-operative volume plus the volume of the defect. For all patients, the subjective and objective parameters improved significantly after surgery. Six and 12 months after surgery, the group with a smaller vaporized volume (<15 g) had a lower reduction of the mean International Prostate Symptom Score (P=0.006 and P=0.004) and quality of life index (P=0.006 and P=0.004) when compared to the group with a greater vaporized volume (> or =15 g). There were no differences in the change of the maximum flow rate and post-void residual based on the vaporized volume. Our findings suggest that the subjective improvement, after a high-power KTP laser vaporization, may be dependent on the vaporized volume obtained after the procedure.

Keyword

Prostate; Prostatic Hyperplasia; Vaporization; Laser Therapy

MeSH Terms

Aged
Aged, 80 and over
Humans
Laser Therapy/*methods
Lasers, Solid-State/*therapeutic use
Male
Middle Aged
Patient Satisfaction
Prostate/pathology/*surgery
Quality of Life
Transurethral Resection of Prostate/*methods
Treatment Outcome
Volatilization

Figure

• 

  Fig. 1 Calculated vaporized volume was determined by the formula: vaporized volume=pre-operative volume-immediate post-operative volume+defected volume. (A) transverse view (preoperative). (B) sagittal view (preoperative). (C) transverse view (postoperative). (D) sagittal view (postoperative). Arrows indicate vaporized volume immediately after photoselective vaporization of the prostate. Calculated vaporized volume was 18.7 mL (50-37+5.7). True vaporized volume was not checkable.

• 

  Fig. 2 Change in clinical parameters according to vaporized volume. (A) International Prostate Symptom Score. (B) Quality of life index. White and black circles circle indicate the scores in the groups with the vaporized volume ≥15 g and <15 g at each month, respectively. Gray and black bars indicate the score changes in the groups with the vaporized volume ≥15 g and <15 g at each month, respectively.

• 

  Fig. 3 Change in clinical parameters according to vaporized volume. (A) maximum flow rate. (B) post-void residual. White and black circles circle indicate the scores in the groups with the vaporized volume ≥15 g and <15 g at each month, respectively. Gray and black bars indicate the score changes in the groups with the vaporized volume ≥15 g and <15 g at each month, respectively.

Reference

1. Barber NJ, Muir GH. High-power KTP laser prostatectomy: the new challenge to transurethral resection of the prostate. Curr Opin Urol. 2004. 14:21–25.

2. Tan AH, Gilling PJ. Lasers in the treatment of benign prostatic hyperplasia: an update. Curr Opin Urol. 2005. 15:55–58.

3. Green JS, Bose P, Thomas DP, Thomas K, Clements R, Peeling WB, Bowsher WG. How complete is a transurethral resection of the prostate? Br J Urol. 1996. 77:398–400.

4. Chen SS, Hong JG, Hsiao YJ, Chang LS. The correlation between clinical outcome and residual prostatic weight ratio after transurethral resection of the prostate for benign prostatic hyperplasia. BJU Int. 2000. 85:79–82.

5. Paick JS, Um JM, Kwak C, Kim SW, Ku JH. Influence of bladder contractility on short-term outcomes of high-power potassium-titanylphosphate photoselective vaporization of the prostate. Urology. 2007. 69:859–863.

6. Littrup PJ, Williams CR, Egglin TK, Kane RA. Determination of prostate volume with transrectal US for cancer screening. Part II Accuracy of in vitro and in vivo techniques. Radiology. 1991. 179:49–53.

7. Sulser T, Reich O, Wyler S, Ruszat R, Casella R, Hofstetter A, Bachmann A. Photoselective KTP laser vaporization of the prostate: first experiences with 65 procedures. J Endourol. 2004. 18:976–981.

8. Kumar SM. Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate. J Urol. 2005. 173:511–513.

9. Sarica K, Alkan E, Luleci H, Tasci AI. Photoselective vaporization of the enlarged prostate with KTP laser: long-term results in 240 patients. J Endourol. 2005. 19:1199–1202.

10. Bachmann A, Schurch L, Ruszat R, Wyler SF, Seifert HH, Muller A, Lehmann K, Sulser T. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol. 2005. 48:965–971.

11. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol. 2006. 20:580–585.

12. Hai MA, Malek RS. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol. 2003. 17:93–96.

13. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int. 2006. 97:1229–1233.

14. Horasanli K, Silay MS, Altay B, Tanriverdi O, Sarica K, Miroglu C. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial. Urology. 2008. 71:247–251.

15. Pfitzenmaier J, Gilfrich C, Pritsch M, Herrmann D, Buse S, Haferkamp A, Djakovic N, Pahernik S, Hohenfellner M. Vaporization of prostates of >or=80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mL. BJU Int. 2008. 102:322–327.

16. Reich O, Bachmann A, Schneede P, Zaak D, Sulser T, Hofstetter A. Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol. 2004. 171(6 Pt 1):2502–2504.

17. Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology. 2004. 64:1155–1159.

18. Tugcu V, Tasci AI, Sahin S, Ordekci Y, Karakas OF, Zorluoglu F. Outcomes of 80 W KTP laser vaporization of the large prostate. Urol Int. 2007. 79:316–320.

19. Rajbabu K, Chandrasekara SK, Barber NJ, Walsh K, Muir GH. Photoselective vaporization of the prostate with the potassium-titanylphosphate laser in men with prostates of >100 mL. BJU Int. 2007. 100:593–598.